Pancreatic Cancer Trial, Recruiting NCT06855485 Sponsor: Asan Medical Center Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT06855485
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with a fluid collection near the pancreas, specifically a pancreatic or peripancreatic pseudocyst, or a walled-off area of dead tissue that contains less than 30% solid material
  • People whose condition is suitable for a drainage procedure guided by endoscopic ultrasound (a type of internal imaging using a flexible tube and sound waves)
  • People who are able to give their agreement to participate and follow the study procedures

Who may not be able to join:

  • People under 18 years of age
  • People whose fluid collection is not yet mature enough for drainage, is a type of cyst that may be cancerous, involves an abnormal bulging blood vessel, or where multiple separate fluid collections need draining at the same time
  • People with blood clotting problems that are not well controlled, including certain abnormal blood test results (confirm with trial site) or other bleeding disorders
  • People whose anatomy or other technical factors make the ultrasound-guided drainage procedure unsuitable
  • People who have previously had a severe allergic reaction to the materials used in stents (small tubes used to keep a drainage passage open)
  • People who are pregnant or who may be pregnant
  • People who are currently taking part in another clinical trial that could affect this study's results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dongwook Oh, MD, PhD, Asan Medical Center

Phone: 82-2-3010-3914

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 February 2025
Est. completion
30 August 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Clinical Success

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov